HHS Applauds FTC Action to Protect Children from Deceptive WPATH Guidelines
Clinical Scorecard: HHS Commends FTC for Legal Measures to Safeguard Children Against Misleading WPATH Guidelines
At a Glance
| Category | Detail |
|---|
| Condition | Pediatric Gender Dysphoria |
| Key Mechanisms | Concerns regarding evidence base, guideline-development process, and conflicts of interest in pediatric gender medicine. |
| Target Population | Children experiencing gender dysphoria |
| Care Setting | Healthcare systems in the United States and internationally |
Key Highlights
- HHS commended FTC for legal action against WPATH for deceptive practices.
- Concerns raised about WPATH's SOC-8 guideline development process.
- HHS report identified weaknesses in evidence base and conflicts of interest.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
- Suppression of systematic reviews of evidence.
- Substantial financial and intellectual conflicts of interest.
Patient & Prescribing Data
Children with gender dysphoria
Concerns about the quality and integrity of treatment guidelines.
Clinical Best Practices
Related Resources & Content
